-
My Account
In App
My Account
BSE Live
Oct 24, 16:01Prev. Close
1512.85
Open Price
1500.05
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Oct 24, 15:55Prev. Close
1512.60
Open Price
1512.00
Bid Price (Qty.)
1474.50 (28)
Offer Price (Qty.)
0.00 (0)
| Balance Sheet of Concord Biotech (in Rs. Cr.) | Mar 25 | Mar 24 | |
| 12 mths | 12 mths | ||
| EQUITIES AND LIABILITIES | |||
| SHAREHOLDER'S FUNDS | |||
| Equity Share Capital | 10.46 | 10.46 | |
| Total Share Capital | 10.46 | 10.46 | |
| Reserves and Surplus | 1,802.26 | 1,516.18 | |
| Total Reserves and Surplus | 1,802.26 | 1,516.18 | |
| Total Shareholders Funds | 1,812.72 | 1,526.65 | |
| Minority Interest | 0.00 | 0.00 | |
| NON-CURRENT LIABILITIES | |||
| Long Term Borrowings | 0.00 | 0.00 | |
| Deferred Tax Liabilities [Net] | 34.02 | 28.06 | |
| Other Long Term Liabilities | 0.63 | 1.89 | |
| Long Term Provisions | 2.82 | 1.96 | |
| Total Non-Current Liabilities | 37.47 | 31.91 | |
| CURRENT LIABILITIES | |||
| Short Term Borrowings | 0.38 | 6.23 | |
| Trade Payables | 113.04 | 94.44 | |
| Other Current Liabilities | 65.10 | 37.59 | |
| Short Term Provisions | 5.54 | 3.90 | |
| Total Current Liabilities | 184.06 | 142.16 | |
| Total Capital And Liabilities | 2,034.25 | 1,700.71 | |
| ASSETS | |||
| NON-CURRENT ASSETS | |||
| Tangible Assets | 794.09 | 575.00 | |
| Intangible Assets | 0.60 | 0.32 | |
| Capital Work-In-Progress | 50.13 | 211.48 | |
| Fixed Assets | 845.34 | 786.80 | |
| Non-Current Investments | 18.73 | 2.06 | |
| Deferred Tax Assets [Net] | 0.00 | 0.00 | |
| Long Term Loans And Advances | 0.00 | 0.00 | |
| Other Non-Current Assets | 34.94 | 15.62 | |
| Total Non-Current Assets | 899.01 | 804.48 | |
| CURRENT ASSETS | |||
| Current Investments | 316.54 | 243.70 | |
| Inventories | 239.67 | 207.95 | |
| Trade Receivables | 521.65 | 349.61 | |
| Cash And Cash Equivalents | 1.18 | 47.02 | |
| Short Term Loans And Advances | 0.00 | 0.00 | |
| OtherCurrentAssets | 56.20 | 47.94 | |
| Total Current Assets | 1,135.24 | 896.23 | |
| Total Assets | 2,034.25 | 1,700.71 | |
| OTHER ADDITIONAL INFORMATION | |||
| CONTINGENT LIABILITIES, COMMITMENTS | |||
| Contingent Liabilities | 26.67 | 26.75 | |
| BONUS DETAILS | |||
| Bonus Equity Share Capital | 7.85 | 7.85 | |
| NON-CURRENT INVESTMENTS | |||
| Non-Current Investments Quoted Market Value | 17.25 | 0.00 | |
| Non-Current Investments Unquoted Book Value | 1.47 | 0.00 | |
| CURRENT INVESTMENTS | |||
| Current Investments Quoted Market Value | 316.54 | 243.70 | |
| Current Investments Unquoted Book Value | 0.00 | 0.00 |
22.08.2025
Concord Biotech Standalone June 2025 Net Sales at Rs 203.99 crore, down 5.47% Y-o-Y
12.06.2025
Concord Biotech Standalone March 2025 Net Sales at Rs 429.88 crore, up 34.77% Y-o-Y
05.06.2025
Concord Biotech Consolidated March 2025 Net Sales at Rs 429.88 crore, up 34.77% Y-o-Y
04.03.2025
Concord Biotech Consolidated December 2024 Net Sales at Rs 244.22 crore, up 1.42% Y-o-Y
